February 2022 Edition
BioethicsNews en inglés

INSTITUTE OF LIFE SCIENCES

No. 103 - February 2022

Contact us HERE

SPECIAL REPORTS

Are we close to getting “universal” organs for transplants?

Scientists in Toronto, Canada, have developed a technique that could make organs for transplantation suitable for any recipient, avoiding the need to find compatible organs, facilitating equity in the allocation of this valuable medical resource. The research, published in Science Translational Medicine, has been carried out on donor lungs maintained ex vivo, that is, outside the body, but it involves …

Read more
Are we close to getting “universal” organs for transplants?

Artificial pregnancy: a step forward or backward?

Artificial pregnancy: a step forward or backward?
Chinese researchers claim to have built an artificial womb that could carry an artificial pregnancy. Some media are reporting a research study published in the Chinese "Journal of Biomedical Engineering", conducted by researchers from the Suzhou Institute of Biomedical Engineering and Technology in China. The team claim to have built an artificial womb that can simulate the functions of the …

Read more

New advances in organoids, old ethical problems

Scientists from Cincinnati (Ohio) have developed the most complex stomach organoids to date, using embryonic stem cells. The biology of tissues and organs is difficult to study in mammals, especially in humans. However, advances in stem cell culture have made it possible to generate tiny three-dimensional tissues in vitro, called organoids. These organ models reproduce some of the anatomical and …

Read more
New advances in organoids, old ethical problems

Who is free from scientific fraud? Analysis of research in Norway

scientific fraud
A recent article published in the journal Science and Engineering Ethics presents the results of a national survey conducted in 2018 for the project “Research Integrity in Norway” about scientific fraud. A total of 7,291 responses were obtained in a questionnaire sent out to 31,206 Norwegian researchers, and the prevalence of certain fraudulent attitudes and practices in research was analyzed, …

Read more

NEWS and VIEWS

First woman with HIV remission using umbilical cord stem cells

HIV (human immunodeficiency virus) is a virus that attacks the body's immune system, weakening the response to infections or cancers and increasing the risk of cardiovascular problems and other complications. Currently there is no effective cure, although the administration of new antiretrovirals can contain the infection until it becomes asymptomatic, requiring lifelong treatment. According to the latest data from the …

Read more
First woman with HIV remission by umbilical cord stem cells

Colombia decriminalizes abortion up to the sixth month of gestation

Colombia decriminalizes abortion up to the sixth month of gestation
The extension of the "culture of death", which legitimizes homicide in more and more circumstances, finds a dramatic example in Colombia after the decriminalization of abortion. Pioneer in the legalization of euthanasia in Latin America, now it returns to lead the set of countries that facilitate the elimination of human embryos in the womb of their mothers, which extends until …

Read more

For the first time, a robot performs surgery without human help

A robot has performed surgery without human guidance. It was a "delicate and complex" intervention in which two ends of a pig's intestine were connected. Undoubtedly, this fact represents a new step towards fully automated surgery in humans. The protagonist is STAR, a robot designed by a team of researchers from Johns Hopkins University (United States), which had …

Read more
For the first time, a robot performs surgery without human help

Study analyzes FDA data on chemical abortions

Study analyzes FDA data on chemical abortions
The study, published in Health Services Research and Managerial Epidemiology, claims there is a "significant" gap in U.S. Food and Drug Administration (FDA) reporting of chemical abortions due to pill complications, raising questions about whether officials were informed when they deregulated its use in December. This month, the Food and Drud Administration (FDA) cited data from adverse event (AE) reporting …

Read more

Pregnant and lactating women: “therapeutic orphans”?

Clinical research on some drugs for pregnant and lactating women sometimes tries to stop for legal, ethical and safety reasons, when there is not enough clinical evidence to give them the desired reliability. This is because some drugs used in this population group have a potential risk of adverse effects for children. Animal experimentation is not applicable in most cases …

Read more
Pregnant and lactating women: “therapeutic orphans”?
Data Protection Policy
Your email address is listed in our database in order to continue to send you information that we consider of interest. Nevertheless, in accordance with Spanish laws on data protection, particularly Law 34/2002 on Information Society Services and E-Commerce, you can unsubscribe from receiving these types of notifications at any time, and delete your data from our listing, through the following link: UNSUBSCRIBE. In accordance with current legislation on personal data protection, you can also exercise your rights of access, rectification, deletion, portability, limitation and opposition, as appropriate, by sending a written request, together with a photocopy of your identity document, to: UCV-LOPD Observatorio de Bioética, Plaza San Agustín, 3 Entlo. B Puerta C 46002 Valencia or, where necessary, to our Delegate in Data Protection dpd@ucv.es
BioethicsNews en inglés
Unsubscribe | Manage your subscription
Bioethics Observatory - Institute of Life Sciences - Catholic University of Valencia
Email Marketing Powered by MailPoet